ADVFN Logo ADVFN
Donnée du Marché
Actualité
Outils
Donnée du Marché
Discover

Hot Features

Follow Feed

Rester connecter avec les traders et investisseurs dans notre communauté Follow Feed.

Flux des Options

Explorez des données complètes sur les options et utilisez les filtres avancés avec Options Flow.

Moniteur

Organisez et surveillez vos d'actions et actifs avec le Moniteur.
Se connecter Premium IconPremium Help Menu
CAC 40
7 407,86
-0,31%
Dow Jones
42 085,34
0,35%
DAX
20 137,22
-0,42%
Brent Oil
80,585
-0,04%
Bitcoin
92 128,80
-2,52%
Registration Strip Icon for discussion Inscrivez-vous pour interagir sur nos forums actifs pour discuter avec des investisseurs aux idées similaires.
S'inscrire
  1. Accueil
  2. Investir
  3. Actions
  4. Canadá
  5. TSXV

  6. ICO Therapeutics Inc (ICO) Cours

ICO Therapeutics Inc

ICO Therapeutics Inc (ICO)

TSXV
0,105
0,00
( 0,00% )
Mis à jour : 01:00:00
Retardé de 15 minutes

Votre Hub pour des idées et discussions en direct en temps réel

Premium

Statistiques et détails clés

Dernier
0,105
Prix Achat
0,07
Prix Vente
0,07
Volume échangé
-
0,00 Fourchette du Jour 0,00
0,105 Plage de 52 semaines 0,105
Cap du marché
11,843M
Clôture Veille
0,105
Ouverture
-
Dernière Transaction
Dernière heure de transaction
-
Volume financier
-
VWAP
-
Volume moyen (3 m)
-
Actions en circulation
112 792 000
Rendement du Dividende
-
Ratio Cours sur Bénéfices
-6,03
Bénéfice par action (BPA)
-0,14
Chiffre d'affairess
-
Bénéfice net
-15,89M

À propos de ICO Therapeutics Inc

Secteur
Coml Physical, Biologcl Resh
Industrie
Pharmaceutical Preparations
Site Web
www.satellos.com
Siège social
Toronto, Ontario, Can
Fondé
2007
ICO Therapeutics Inc est coté dans le secteur Coml Physical, Biologcl Resh de la TSX Venture Exchange avec le ticker ICO. Le dernier cours de clôture d'ICO Therapeutics était de $0,11. Au cours de la dernière année, les actions de ICO Therapeutics ont été négociées dans une fourchette de prix de $ 0,105 à $ 0,105.

ICO Therapeutics compte actuellement 112 792 000 actions en circulation. La capitalisation boursière d'ICO Therapeutics est de $11,84 million. ICO Therapeutics a un ratio cours/bénéfice (ratio PE) de -6.03.

ICO Dernières nouvelles

Plus de nouvelles

Bertilimumab Chosen as a Top Autoimmune/Anti-Inflammatory Projects to Watch

Bertilimumab Chosen as a Top Autoimmune/Anti-Inflammatory Projects to Watch PR Newswire NEW YORK and HERZLIYA PITUACH, Israel, Dec. 1, 2014 NEW YORK and HERZLIYA PITUACH, Israel, Dec. 1, 2014...

01 Décembre 2014
PR Newswire (US)

iCo Therapeutics Announces Third Quarter 2014 Financial Results and Corporate Update

iCo Therapeutics Announces Third Quarter 2014 Financial Results and Corporate Update PR Newswire VANCOUVER, Nov. 28, 2014 VANCOUVER, Nov. 28, 2014 /PRNewswire/ - iCo Therapeutics ("iCo"...

28 Novembre 2014
PR Newswire (US)

Immune Pharmaceuticals Inc. Completes Underwriter's Exercise Of Partial Over-Allotment Option

Immune Pharmaceuticals Inc. Completes Underwriter's Exercise Of Partial Over-Allotment Option Immune has raised now total gross proceeds of $10.685 million in November 2014 PR Newswire NEW YORK...

26 Novembre 2014
PR Newswire (US)

Immune Pharmaceuticals Inc. Announces Closing Of Public Offering Of Common Stock And Warrants

Immune Pharmaceuticals Inc. Announces Closing Of Public Offering Of Common Stock And Warrants Immune has raised total gross proceeds of $9.625 million in November 2014 PR Newswire NEW YORK and...

25 Novembre 2014
PR Newswire (US)

Immune Pharmaceuticals Inc. Announces Pricing Of Public Offering Of Common Stock And Warrants To Purchase Common Stock

Immune Pharmaceuticals Inc. Announces Pricing Of Public Offering Of Common Stock And Warrants To Purchase Common Stock PR Newswire NEW YORK and HERZLIYA PITUACH, Israel, Nov. 20, 2014 NEW YORK...

20 Novembre 2014
PR Newswire (US)

Immune's CEO To Present on Personalized Medicine at the 2014 NY/ NJ CEO Biotech Conference

Immune's CEO To Present on Personalized Medicine at the 2014 NY/ NJ CEO Biotech Conference Immune developing personalized medicine drugs for auto-immune diseases and cancer PR Newswire NEW YORK...

11 Novembre 2014
PR Newswire (US)

iCo Therapeutics Announces Oral Amphotericin Presentations at AAPS

iCo Therapeutics Announces Oral Amphotericin Presentations at AAPS PR Newswire VANCOUVER, Nov. 4, 2014 VANCOUVER, Nov. 4, 2014 /PRNewswire/ - iCo Therapeutics ("iCo" or "the...

04 Novembre 2014
PR Newswire (US)

iCo Therapeutics Announces Advancement of Oral Amphotericin B Program

iCo Therapeutics Announces Advancement of Oral Amphotericin B Program PR Newswire VANCOUVER, Oct. 22, 2014 VANCOUVER, Oct. 22, 2014 /PRNewswire/ - iCo Therapeutics ("iCo" or "the...

22 Octobre 2014
PR Newswire (US)

New Clinical Data Supports Development Of Bertilimumab In Both Ulcerative Colitis And Crohn's Disease

New Clinical Data Supports Development Of Bertilimumab In Both Ulcerative Colitis And Crohn's Disease Immune Pharmaceuticals Recently Initiated Phase II Clinical Trial in Ulcerative Colitis PR...

22 Octobre 2014
PR Newswire (US)

Immune Pharmaceuticals Initiates Phase II Clinical Trial In Ulcerative Colitis

Immune Pharmaceuticals Initiates Phase II Clinical Trial In Ulcerative Colitis Company Recently Initiated Phase II in Bullous Pemphigoid PR Newswire CAMBRIDGE, Mass. and HERZLIYA PITUACH, Israel...

18 Septembre 2014
PR Newswire (US)
PériodeVariationVariation %Ouver.HautBasMoyenne Vol. Quot.VWAP
1000.1050.1050.10500CS
4000.1050.1050.10500CS
12000.1050.1050.10500CS
26000.1050.1050.10500CS
52000.1050.1050.10500CS
156000.1050.1050.10500CS
2600.03400.0750.160.022339900.07709048CS

ICO - Frequently Asked Questions (FAQ)

What is the current ICO Therapeutics share price?
The current share price of ICO Therapeutics is $ 0,105
How many ICO Therapeutics shares are in issue?
ICO Therapeutics has 112 792 000 shares in issue
What is the market cap of ICO Therapeutics?
The market capitalisation of ICO Therapeutics is CAD 11,84M
What is the 1 year trading range for ICO Therapeutics share price?
ICO Therapeutics has traded in the range of $ 0,105 to $ 0,105 during the past year
What is the PE ratio of ICO Therapeutics?
The price to earnings ratio of ICO Therapeutics is -6,03
What is the reporting currency for ICO Therapeutics?
ICO Therapeutics reports financial results in CAD
What is the latest annual profit for ICO Therapeutics?
The latest annual profit of ICO Therapeutics is CAD -15,89M
What is the registered address of ICO Therapeutics?
The registered address for ICO Therapeutics is 79 WELLINGTON STREET WEST, 33RD FLOOR, TORONTO, ONTARIO, M5K 1N2
What is the ICO Therapeutics website address?
The website address for ICO Therapeutics is www.satellos.com
Which industry sector does ICO Therapeutics operate in?
ICO Therapeutics operates in the PHARMACEUTICAL PREPARATIONS sector

Moteurs

Voir tout
  • Volume
  • % Gagnants
  • % Perdants
SymbolePrixVol.
MVYMoovly Media Inc
$ 0,01
(100,00%)
39k
CTGCentenario Gold Corp
$ 0,02
(100,00%)
650,1k
CTACentaurus Energy Inc
$ 2,90
(63,84%)
4,1k
TOHTotal Helium Ltd
$ 0,015
(50,00%)
3k
KSKlondike Silver Corp
$ 0,015
(50,00%)
118,33k
ADG.HArcus Development Group Inc
$ 0,005
(-66,67%)
11k
TVITVI Pacific Inc
$ 0,005
(-50,00%)
20k
MNLXMiniluxe Holding Corp
$ 0,465
(-38,00%)
4,4k
WAVEWaverley Pharma Inc
$ 0,01
(-33,33%)
4k
MTLOMartello Technologies Group Inc
$ 0,01
(-33,33%)
22k
XBOTRealbotix Corp
$ 0,65
(6,56%)
6,68M
QNCQuantum Emotion Corp
$ 0,70
(-22,22%)
3,72M
WWTWater Ways Technologies Inc
$ 0,005
(0,00%)
2,1M
THRMTherma Bright Inc
$ 0,045
(12,50%)
1,57M
GPUSAlset AI Ventures Inc
$ 0,17
(-8,11%)
1,48M

Forums

Afficher les forums
Aucune Discussion Trouvée
Ajouter une Discussion

Dernières Valeurs Consultées

TSXV
ICO
ICO Therapeutics
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

France
Société
Entreprise
Popular
Obtenir l'application
App Store
Google Play

Assistance: support@advfn.fr

En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales

© 2025 ADVFN PLC - Tous droits réservés